SCHEMBL29411410

SCHEMBL29411410

Cc1ccc(C(=O)NCCCc2ccc(-c3ccccc3F)cc2)cn1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.55
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
EPHX2 P34913 1/20 0.49
HIF1A Q16665 1/20 0.47
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NAMPT P43490 4/20 0.46
CYP19A1 P11511 1/20 0.46
PPARG P37231 1/20 0.46
POLB P06746 1/20 0.46
CNR1 P21554 1/20 0.45
PTAFR P25105 1/20 0.45
KMT2A Q03164 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
KCNH2 Q12809 1/20 0.44
SCN5A Q14524 1/20 0.44
SCN9A Q15858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045178 1.00 KDM4E (0.55) KDM4ENPC1RAB9AEPHX2HIF1A
SCHEMBL21235030 0.89 EPHX2 (0.52) NPC1RAB9AEPHX2HIF1AALDH1A1
SCHEMBL21045331 0.89 HIF1A (0.49) KDM4ENPC1RAB9AEPHX2HIF1A
SCHEMBL29411657 0.89 HIF1A (0.49) KDM4ENPC1RAB9AEPHX2HIF1A
SCHEMBL21045159 0.89 PTAFR (0.53) KDM4ENPC1RAB9AEPHX2ALDH1A1
SCHEMBL29411435 0.89 PTAFR (0.53) KDM4ENPC1RAB9AEPHX2ALDH1A1
SCHEMBL29411600 0.88 NPC1 (0.50) NPC1RAB9AEPHX2HIF1AALDH1A1
SCHEMBL21045430 0.88 NPC1 (0.50) NPC1RAB9AEPHX2HIF1AALDH1A1
SCHEMBL21045235 0.87 NAMPT (0.56) NPC1RAB9AEPHX2HIF1AALDH1A1
SCHEMBL29411412 0.87 NAMPT (0.56) NPC1RAB9AEPHX2HIF1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188035-A1 TUBULIN INHIBITORS LIN BIOSCIENCE LLC (US) 2025-06-12 US disclosed
US-12247010-B2 Tubulin inhibitors LIN BIOSCIENCE INC. (TW) 2025-03-11 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB KDM4E 4032/4885NPC1 421/4885RAB9A 959/4885
US-12247010-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB KDM4E 4032/4885NPC1 421/4885RAB9A 959/4885
US-20250188035-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB KDM4E 4032/4885NPC1 421/4885RAB9A 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.